Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Selective Serotonin Reuptake Inhibitor Discontinuation: Side Effects and Other Factors That Influence Medication Adherence

Goethe, John W., Woolley, Stephen B., Cardoni, Alex A., Woznicki, Brenda A., Piez, Deborah A. · 2007 · Journal of Clinical Psychopharmacology

Abstract

OBJECTIVE: Patients with major depression discontinue taking their antidepressants for many reasons. Although side effects are often cited as the reason for discontinuation, few prospective studies have addressed this question, and none has specifically examined discontinuation in patients with severe depression. METHOD: Inpatients and outpatients treated with a selective serotonin reuptake inhibitor for major depressive disorder were identified after admission. Three months later, patients were contacted and interviewed to determine antidepressant usage and the side effects experienced, including when these were experienced and their severity. RESULTS: Between October 2001 and April 2003, 406 English- or Spanish-speaking patients aged 18 to 75 years were followed up. One in 4 patients discontinued the index antidepressant. Among specific side effects noted, only "change in weight" and "anxiety" were significant predictors of discontinuation after controlling for confounders. Experiencing 1 or more "extremely" bothersome side effects was associated with more than a doubling of the risk of discontinuation, but the presence of side effects and side effects less severe than "extremely" bothersome were not significant predictors. There were no differences among selective serotonin reuptake inhibitor antidepressants in either the presence/absence of side effects or in the discontinuation rates. CONCLUSION: The results suggest that the contribution of side effects to antidepressant discontinuation is more complex than previously suggested. Disparate findings from earlier studies may reflect aspects of study design, such as examining populations whose severity of depression varied widely or not controlling for important confounding factors. Future research should separately examine high-risk groups (or control for severity of depression) and carefully rule out other potential contributors to discontinuation.

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0b013e31815152a5

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Research works printed but not linked: 2

  1. Bull, 2002, Discontinuing or switching selective serotonin-reuptake inhibitors., Ann Pharmacother, 36, 578, 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
  2. Anderson, 1995, Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis., BMJ, 310, 1433, 10.1136/bmj.310.6992.1433 · DOI · Paper page

Cited by

See all 113

Metadata

Authors
Goethe, J. W., Woolley, S. B., Cardoni, A. A., Woznicki, B. A., & Piez, D. A.
Affiliations
Hartford Hospital (US)
Corresponding author
Woolley, Stephen B.
Venue
Journal of Clinical Psychopharmacology
Published
2007-10
Volume
27
Issue
5
Pages
451-458
ISSN
0271-0749 (ISSN-L)
OpenAlex
W1981417884
Cited by
113
References
33
Citations by year
2026: 1 · 2025: 6 · 2024: 8 · 2023: 2 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 6 · 2014: 5 · 2013: 14 · 2012: 4
FWCI
4.68
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
selective serotonin reuptake inhibitors, antidepressant discontinuation, major depressive disorder, antidepressant side effects, weight change, anxiety, severe depression, predictors of discontinuation
MeSH terms
Adolescent, Adult, Aged, Anxiety, Body Weight, Major Depressive Disorder, Depressive Disorder, Major, Female, Follow-Up Studies, Humans, Male, Middle Aged, Risk Factors, Multivariate Analysis, Treatment Refusal, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective Serotonin Reuptake Inhibitor Discontinuation: Side Effects and Other Factors That Influence Medication Adherence. https://app.cochat.ai/papers/10.1097/jcp.0b013e31815152a5
The paper
Goethe, J. W., Woolley, S. B., Cardoni, A. A., Woznicki, B. A., & Piez, D. A. (2007). Selective Serotonin Reuptake Inhibitor Discontinuation: Side Effects and Other Factors That Influence Medication Adherence. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0b013e31815152a5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.